Adrafinil 300mg

Description

What is Adrafinil 300 mg?

Adrafinil 300 mg is supplied by NeuroPeak Labs in capsules, each containing 300 mg of adrafinil as declared on the label. The chemical name of the compound is 2-[(diphenylmethyl)sulfinyl]acetohydroxamic acid, and the capsule shell is vegetarian HPMC. Those are the facts printed on the container, and this page keeps to them.

Adrafinil is not an authorised medicine in the European Union. No regulator has assessed it, no marketing authorisation exists for it, and consequently there is no approved patient information leaflet and no summary of product characteristics to consult — a material difference from the prescription medicines listed elsewhere in this shop.

Its legal status differs from country to country, is not the same everywhere in the EU, and is subject to change; the responsibility for checking the rules that apply where an order is delivered rests with the buyer, before ordering.

Because it is not an authorised medicine, adrafinil has no established suitability criteria that a shop could apply, and NeuroPeak applies none. We do not assess whether it is appropriate for anyone, we do not issue prescriptions and we give no dosing advice of any kind. Anyone considering this product should discuss it with a doctor or pharmacist first, and mention every other medicine, supplement and health condition in that conversation. This page describes a product; it is not medical advice and cannot substitute for it.

What’s in the pack

Adrafinil is shipped in the sealed container in which it was packed, with the batch number and expiry date on the label. Capsules are not counted out into bags or transferred into our own containers, and nothing is relabelled between our warehouse and your address.

• Active compound: adrafinil (2-[(diphenylmethyl)sulfinyl]acetohydroxamic acid)
• Strength declared: 300 mg per capsule
• Capsule shell: vegetarian HPMC
• Batch number: printed on the label of every container, as applied at packing
• Seal: packed sealed and dispatched sealed, never decanted or repackaged
• Leaflet: none, and none exists — no regulator has assessed the compound, so there is no approved leaflet to pack
• Storage: cool, dry place, away from direct sunlight
• Shelf life: 24 months from manufacture; the expiry date is printed on the container
• Testing: independent laboratory analysis of incoming stock, with a reference report available to download

Pack sizes currently listed, with the price of each and the price per unit:

Paying in Bitcoin takes 20% off at checkout.

The figures shown are the ones in force today. The per-unit figure falls as the pack size rises, and paying in Bitcoin takes the percentage shown beneath the table off the whole order automatically at checkout — there is no coupon code to enter.

Manufacturer

This product is packed and supplied under the NeuroPeak Labs name. These are the particulars we can evidence, and we assert nothing beyond them:

• Supplied by: NeuroPeak Labs, under whose name the product is packed and supplied.
• Printed on the label: the declared strength, the batch number and the expiry date.
• Independent batch testing: every batch is sampled on arrival and sent to an independent laboratory before it is listed for sale.
• Certificate of Analysis: a reference report for the substance is available to download. It identifies the compound and confirms the declared content of the capsule.
• Traceable:
• Sealed and never repackaged: stock is stored sealed at our EU warehouse and dispatched sealed.

The certificate is a document about what is in the container and nothing more. It is not evidence about an outcome for any person. We describe this product only in terms the label and the certificate support, and we do not attribute approvals, assessments or markets we could not evidence.

Adrafinil and the other brands in this category

Where a shop lists more than one brand of the same compound at the same declared strength, the differences between them are the company behind the product, the pack sizes offered and the price per unit — not the effect. A product that meets the same specification as another does not begin sooner, last longer or arrive more strongly than it, and comparison tables ranking brands as cleaner, smoother or more potent describe a difference that is not on any label. We do not publish that kind of table for any product. The table below lists what is currently in this category with its maker and price per unit.

This product’s row is marked. Rows are sorted by price per unit.

Dosing: why we do not advise

This section carries no self-dosing, timing, administration, stacking or cycling protocol, and the heading says so plainly rather than promising guidance the text then withholds. Suitability and individual use must be settled with a doctor or pharmacist; no leaflet is supplied with this product and none exists, because no regulator has assessed adrafinil and no marketing authorisation for it is in force anywhere in the European Union. Do not combine or alternate this with medicines without professional advice.

No regulator has published a recognised side-effect list for this compound, and none exists to reproduce here. What circulates instead comes from non-regulatory sources: user reports, and the historical French documentation from the period when adrafinil was marketed under the name Olmifon. That marketing ended in 2011 and nothing has replaced it.

Concerns about effects on the liver belong to that history, and what should follow from them is a question for a doctor — not a protocol for a shop to issue, so we give no monitoring, testing or duration guidance of any kind. If any reaction occurs, stop and seek medical advice.

NeuroPeak hold no medical history and assess no one, so we give no dosing advice. The absence of an assessment by a medicines authority is a reason for caution, not a gap for a seller to fill in.

Side effects and safety

What documentation does not exist

Adrafinil is not an authorised medicine, so the documents an authorised medicine carries are absent here:

• no regulator-approved leaflet listing its side effects;
• no official contraindication list;
• no approved warnings.

The absence of that documentation is itself a reason to take medical advice before use rather than a reassurance.

When to stop and seek urgent medical help

Stop and seek medical help immediately if any of the following occur:

• a skin rash
• blistering
• ulceration of the mouth or eyes
• swelling of the face or throat
• difficulty breathing
• fever
• chest pain
• an irregular heartbeat
• hallucinations
• agitation
• depression or thoughts of self-harm

A rash can be the first sign of a serious reaction and is a reason to stop and get medical attention rather than to wait it out.

Other medicines, conditions and storage

Other medicines and conditions: speak to a doctor or pharmacist before use if any of the following applies:

• taking any other medicine, including hormonal contraception;
• pregnant or breastfeeding;
• a heart condition;
• high blood pressure;
• liver or kidney impairment;
• a history of psychiatric illness.

Interactions are possible and cannot be ruled out here.

Storage. Keep the tablets in their original packaging at normal room temperature, dry and away from direct light, and out of the sight and reach of children. Do not use the product after the expiry date printed on the carton and the blister.

Shipping and quality

• EU warehouse: orders leave our European distribution centre within 24-48 hours; costs and delivery times per country are on the shipping page.
• Tracked delivery: every parcel is tracked end to end, with the tracking number emailed on handover to the carrier.
• Discreet packaging: a plain, unmarked box with a neutral sender name and no indication of the contents on the outside.
• Sealed containers: never repackaged or decanted, with batch number and expiry date visible on the label.
• Batch tested: independent laboratory analysis of incoming stock, with a reference report available to download.
• Delivery guarantee: a tracked shipment that does not arrive is reshipped at no cost or refunded in full.
• Bitcoin discount: paying in Bitcoin applies the discount shown at checkout automatically.

Frequently asked questions

Do I need a prescription to order?

There is no prescription to produce: adrafinil is not an authorised medicine in the European Union, so it is not a prescription-only medicine either. That is not the same as being unregulated. Its legal status differs from country to country, is not the same everywhere in the EU and is subject to change, and the responsibility for checking the rules that apply where an order is delivered rests with the buyer, before ordering.

Is there a leaflet, and does the old Olmifon documentation count as one?

No, to both. A patient information leaflet is a document a regulator approves, and no marketing authorisation exists for adrafinil, so there is no approved leaflet to pack and no summary of product characteristics to consult. Adrafinil was once marketed in France under the name Olmifon; that marketing ended in 2011 and nothing has replaced it, which makes the French documentation from that period historical rather than current. Concerns about effects on the liver belong to that history, and what should follow from them is a question for a doctor — we issue no monitoring, testing or duration guidance of any kind.

How much is one capsule, and how do I pay?

The price of each pack size and the price per unit are in the pack table above, and the per-unit figure falls as the pack size rises. Payment methods are shown at checkout and listed on our FAQ page; paying in Bitcoin takes the percentage shown beneath the table off the whole order automatically, with no coupon code to enter.

What is the difference between the brands in this category?

The company behind the product, the pack sizes offered and the price per unit. Where two products declare the same compound at the same strength, that is the whole of the difference — not the effect, and we publish no ranking, because nothing on a label supports one.

What does the Certificate of Analysis cover?

The batch number is printed on the pack, so the pack you received can be identified. The report we publish is a reference analysis of the substance rather than of that individual batch, and we do not issue per-batch certificates. The report identifies the compound and confirms the declared content of the capsule. If the two do not match, do not use the product — contact us first.

What happens if the parcel does not arrive?

Every parcel is tracked end to end, and the tracking number is emailed on handover to the carrier. If a tracked shipment does not arrive, we reship at no cost or refund in full. Nothing needs to be claimed under a separate policy: the delivery guarantee applies to every tracked order.

Do you answer questions about dosing, or about whether this is right for me?

No. We hold nobody’s medical history and we assess nobody, so we have no basis for answering a question about quantity, timing or suitability, and our support team will not answer one even if it is put directly. For a compound no medicines authority has assessed there is not even an approved document to fall back on, which makes that conversation more important rather than less. Discuss it with a doctor or pharmacist before use, and mention every other medicine, supplement and health condition.

Our FAQ page covers legality and import rules by country, delivery times, payment methods and the Bitcoin discount, the delivery guarantee, and what the Certificate of Analysis covers. If your question is not answered there, contact us.